Demand surged across US, UAE, driven by proven ability to deliver sustained weight loss Dubai: Anti-obesity drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have moved rapidly from niche diabetes treatments to some of the most widely discussed and prescribed medicines in both the US and the UAE. Demand has surged across both markets, driven by …
